<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067599</url>
  </required_header>
  <id_info>
    <org_study_id>1R01CA141531-01</org_study_id>
    <secondary_id>1R01CA141531</secondary_id>
    <nct_id>NCT01067599</nct_id>
  </id_info>
  <brief_title>Novel Determinants and Measures of Smokeless Tobacco Use: Study 2</brief_title>
  <official_title>Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research project will determine the level of nicotine in ST products that will lead to
      the greatest reduction in toxicant exposure
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, multi-site trial determining the effects of switching smokeless tobacco
      (ST) users to lower toxicant ST products which vary in nicotine levels on biomarkers of
      exposure and patterns of use. ST users will undergo a two week baseline assessment period and
      then randomly assigned to one of three oral tobacco products (lower NNK plus NNN product with
      three different levels of nicotine) for a period of 8-weeks. Follow-up will occur at 9 and 20
      weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2012</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1. To determine if switching to ST products with reduced toxicant levels will result in reduction of biomarkers of exposure and toxicity. 2. To determine the nicotine levels of ST that would lead to the greatest reduction in tobacco toxicant exposure.</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the extent to which varying low nicotine ST products leads to compensatory tobacco use.</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">278</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>Low nicotine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional smokeless tobacco product with 1) NNN plus NNK of &lt;2 μg/gram and nicotine levels of &gt;5 mg/g wet weight</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium nicotine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional smokeless tobacco product with ) NNN plus NNK of &lt;2 μg/gram and nicotine levels of 3-5 mg/g wet weight.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High nicotine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional smokeless tobacco product with NNN plus NNK of &lt;2 μg/gram and nicotine levels of &lt;3 mg/g wet weight</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low nicotine</intervention_name>
    <description>Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.</description>
    <arm_group_label>Low nicotine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medium nicotine</intervention_name>
    <description>Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.</description>
    <arm_group_label>Medium nicotine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High nicotine</intervention_name>
    <description>Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.</description>
    <arm_group_label>High nicotine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Using a consistent and daily amount of ST with specific nicotine and tobacco-specific
             nitrosamine (TSNA) levels for the past year;

          2. In good physical health (no unstable medical condition);

          3. Stable, good mental health (e.g., no recent unstable or untreated psychiatric
             diagnosis, including substance abuse, as determined by the DSM-IV criteria).

        Exclusion Criteria:

          1. Subjects must not be currently using other tobacco or nicotine products.

          2. Female subjects cannot be pregnant or nursing.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorothy Hatsukami, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Research Institute</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2010</study_first_submitted>
  <study_first_submitted_qc>February 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2010</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biomarkers of tobacco exposure</keyword>
  <keyword>Smokeless Tobacco</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

